nimodipine

FDA Drug Profile — nimodipine, Nymalize

nimodipine is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including nimodipine, Nymalize. Available dosage forms: capsule, liquid filled, solution.

Drug Details

Generic Name
nimodipine
Brand Names
nimodipine, Nymalize
Application Number
ANDA077811
Sponsor
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC Codes
3
Dosage Forms
CAPSULE, LIQUID FILLED, SOLUTION
Routes
ORAL
Active Ingredients
NIMODIPINE

Indications and Usage

1 INDICATIONS AND USE Nimodipine oral solution is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I to V). Nimodipine oral solution is a dihydropyridine calcium channel blocker indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I to V). (1)